back to homepage

Archive

Acute Kidney Injury Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Astellas Pharma, Amniotics, Guard Therapeutics, RegeneRx Biopharma, Cerenis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Kidney Injury pipeline constitutes 30+ key companies continuously working towards developing 30+ Acute Kidney Injury treatment therapies, analysis of

Read More

IgA Nephropathy Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, IgA Nephropathy pipeline constitutes 30+ key companies continuously working towards developing 30+ IgA Nephropathy treatment therapies, analysis of Clinical Trials,

Read More

End Stage Renal Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Rockwell Medical Technologies, Aronora, Merck Sharp & Dohme

“End Stage Renal Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the End Stage Renal Disease, historical and forecasted epidemiology as well as the End

Read More

Tendinopathy Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, ZARS Pharma Inc., Merck Sharp, Erasmus Medical Center, CTM Biomed

“Tendinopathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Tendinopathy, historical and forecasted epidemiology as well as the Tendinopathy market trends in the 7MM. DelveInsight’s

Read More

Alport Syndrome Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Eloxx Pharma, Biogen, River 3 Renal Corp., Traverse

“Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in

Read More

Idiopathic Membranous Nephropathy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | MorphoSys, Hoffmann-La Roche, BeiGene, Cerium

“Idiopathic Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Idiopathic Membranous Nephropathy, historical and forecasted epidemiology as well as the Idiopathic Membranous Nephropathy

Read More